Cardiac Stem Cell Regeneration in Metabolic Syndrome

Author(s): Xihui Xu, Jun Ren

Journal Name: Current Pharmaceutical Design

Volume 19 , Issue 27 , 2013

Become EABM
Become Reviewer
Call for Editor


The metabolic syndrome (MetS) is a constellation of multiple metabolic risk factors including obesity, glucose intolerance, insulin resistance, dyslipidemia and hypertension. Individuals with MetS are found to be afflicted with an increased risk of type 2 diabetes mellitus and overall cardiovascular diseases. One of the common comorbidities of MetS is the impairment of heart function en route to loss of cardiomyocytes and ultimately heart failure. Although it is accepted that cardiomyocytes are terminally differentiated, recent evidence has challenged this concept to indicate the ability of cardiomyocytes to regenerate from progenitor cells of the heart and other organs. Moreover, it has been suggested that pathological conditions such as MetS may play a role in the regulation of cardiomyocyte regeneration. This mini-review will discuss the role of MetS in the regulatory machineries of cardiomyocyte regeneration.

Keywords: Metabolic syndrome, obesity, diabetes, heart, stem cell, cell regeneration.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Page: [4888 - 4892]
Pages: 5
DOI: 10.2174/1381612811319270011
Price: $65

Article Metrics

PDF: 14